AKRAM MIRDAMADIHA: Open Payments
NPI 1992135909 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,454 in 17 payments from 14 companies in 2025. Trend: 2023 $986 · 2024 $2,599 · 2025 $1,454
Food & beverage: $1,454
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $269 |
| Hologic Sales and Service, LLC | 1 | $150 |
| SANOFI-AVENTIS U.S. LLC | 1 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $123 |
| GENZYME CORPORATION | 1 | $122 |
| Amgen Inc. | 1 | $122 |
| Grifols USA, LLC | 1 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $115 |
| Alnylam Pharmaceuticals Inc. | 1 | $108 |
| Exeltis, USA Inc. | 1 | $103 |
Products named: AUSTEDO XR, APTIMA, TZIELD, JARDIANCE, FABRAZYME, KRYSTEXXA, Prolastin-C Liquid, AMVUTTRA.
Industry payments across TX — which companies pay providers there.
